# EDGAR Filing Document

**Accession Number:** 0001813756
**File Stem:** 0000899243-23-006353
**Filing Date:** 2023-2
**Character Count:** 10200
**Document Hash:** 1d90685f859c2cf78bf927c89e1ffb54
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000899243-23-006353.hdr.sgml**: 20230228

**ACCESSION NUMBER**: 0000899243-23-006353

**CONFORMED SUBMISSION TYPE**: 3

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20230221

**FILED AS OF DATE**: 20230228

**DATE AS OF CHANGE**: 20230228

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Swidler Pamela
- **CENTRAL INDEX KEY:** 0001967250

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-39419
- **FILM NUMBER:** 23681103

**MAIL ADDRESS:**
- **STREET 1:** 177 9TH AVENUE
- **STREET 2:** APT. 3C
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10011
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** WeWork Inc.
- **CENTRAL INDEX KEY:** 0001813756
- **STANDARD INDUSTRIAL CLASSIFICATION:** OPERATORS OF NONRESIDENTIAL BUILDINGS [6512]
- **IRS NUMBER:** 851144904
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 75 ROCKEFELLER PLAZA
- **STREET 2:** 10TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10019
- **BUSINESS PHONE:** (646) 389-3922

**MAIL ADDRESS:**
- **STREET 1:** 75 ROCKEFELLER PLAZA
- **STREET 2:** 10TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10019

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** BowX Acquisition Corp.
- **DATE OF NAME CHANGE:** 20200601

## Ex-24

```
<PRE>
                               POWER OF ATTORNEY

      Know all by these presents that the undersigned hereby constitutes and
appoints Jared DeMatteis as the undersigned's true and lawful primary attorney-
in-fact and Jane Wang as the undersigned's secondary attorney-in-fact to:

    (1)   execute for and on behalf of the undersigned, in the undersigned's
capacity as a beneficial owner of WeWork, Inc. (the "Company"), Forms 3, 4, and
5 in accordance with Section 16(a) of the Securities Exchange Act of 1934 and
the rules thereunder;

    (2)   do and perform any and all acts for and on behalf of the undersigned
which may be necessary or desirable to complete and execute any such Form 3, 4,
or 5 ,complete and execute any amendment or amendments thereto, and timely file
such form with the U.S. Securities and Exchange Commission (the "SEC'') and any
securities exchange or similar authority; and

    (3)   take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be of benefit to,
in the best interest of, or legally required by, the undersigned, it being
understood that the documents executed by  such  attorney-in-fact on  behalf  of
the  undersigned  pursuant  to  this Power  of Attorney shall be in such form
and shall contain such terms and conditions as such attorney-in-fact may approve
in such attorney-in-fact's discretion.

      The undersigned hereby grants to the attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might
or could do if personally present, with full power of substitution or
revocation, hereby ratifying and confirming all that such attorney-in-fact, or
such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to
be done by virtue of this power of attorney and the rights and powers herein
granted. The undersigned also ratifies hereby any action previously taken by the
attorney-in-fact  that would have been authorized by this power of attorney if
it has been in effect at the time such action was taken. The undersigned
acknowledges that the foregoing attorney-in-fact, in serving in such capacity at
the request of the undersigned, is not assuming, nor is the Company assuming,
any of the undersigned's responsibilities to comply with Section 16 of the
Securities Exchange Act of 1934. The primary and secondary attorneys-in-fact may
act separately.

      This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, and 5 with respect  to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorney-in-fact.

      IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to
be executed as of this 13 day of February, 2023.

                                              /s/ Pamela Swidler
                                              ---------------------------
                                              Name: Pamela Swidler
</PRE>
```

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 3

### INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Swidler Pamela<br><sub>(Last) (First) (Middle)</sub><br>75 ROCKEFELLER PLAZA, 10TH FL<br><sub>(Street)</sub><br>NEW YORK, NY 10019<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>WeWork Inc. [ WE ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2023-02-21 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director   [ ] 10% Owner<br>[X] Officer (give title below)   [ ] Other (specify below)<br>_See Remarks_ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities Beneficially Owned

---

|  |  |  |  |
| --- | --- | --- | --- |
| 1. Title of Security | 2. Amount of Securities Beneficially Owned | 3. Ownership Form | 4. Nature of Indirect Beneficial Ownership |
| Common Stock | 21067 | D |  |
| Common Stock | 6196<sup>(1)</sup> | D |  |
| Common Stock | 13769<sup>(2)</sup> | D |  |
| Common Stock | 33333<sup>(3)</sup> | D |  |
| Common Stock | 7184<sup>(4)</sup> | D |  |

---

## Table II - Derivative Securities Beneficially Owned

---

|  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Underlying Securities | 3. Title and Amount of Underlying Securities | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| Stock Option (right to buy) | <sup>(5)</sup> | 2026-08-04 | Common Stock | 3098 | $4.99 | D |  |
| Stock Option (right to buy) | <sup>(6)</sup> | 2027-01-18 | Common Stock | 3178 | $4.99 | D |  |
| Stock Option (right to buy) | <sup>(7)</sup> | 2028-06-12 | Common Stock | 547 | $4.99 | D |  |
| Stock Option (right to buy) | <sup>(8)</sup> | 2029-03-29 | Common Stock | 8762 | $4.99 | D |  |
| Stock Option (right to buy) | <sup>(9)</sup> | 2030-02-10 | Common Stock | 19828 | $2.55 | D |  |

---

### Footnotes:

(1) Represents unvested restricted stock units ("RSUs") granted on January 26, 2021 that convert into common stock on a one-for-one basis. The RSUs will vest on January 26, 2024.

(2) Represents unvested RSUs granted on August 10, 2021 that convert into common stock on a one-for-one basis. The RSUs will vest in equal installments on July 15, 2023 and July 15, 2024.

(3) Represents unvested RSUs granted on March 22, 2022 that convert into common stock on a one-for-one basis. The RSUs will vest in equal installments on January 10, 2024 and January 10, 2025.

(4) Represents unvested RSUs granted on March 22, 2022 that convert into common stock on a one-for-one basis. The RSUs will vest in equal installments on January 10, 2024 and January 10, 2025; provided however, that if the Issuer achieves a certain earnings before interest, taxes, depreciation, and amortization ("EBITDA") milestone no later than December 31, 2023, all of the RSUs will vest on January 10, 2024.

(5) Represents outstanding, unexercised stock options to purchase common stock granted on August 4, 2016. The options are fully vested and exercisable.

(6) Represents outstanding, unexercised stock options to purchase common stock granted on January 18, 2017. The options are fully vested and exercisable.

(7) Represents outstanding, unexercised stock options to purchase common stock granted on June 12, 2018. The options are fully vested and exercisable.

(8) Represents outstanding, unexercised stock options to purchase common stock granted on March 29, 2019. 25% of the options are vested and exercisable, 15% of the remaining options vest on each of March 16, 2023, March 16, 2024 and March 16, 2025, and the remaining 30% of the options vest on March 16, 2026.

(9) Represents outstanding, unexercised portion of stock options to purchase common stock granted on June 18, 2020. The options are fully vested and exercisable.

**Remarks:**
Exhibit 24 - Power of Attorney

Chief Legal Officer, Chief Compliance Officer and Secretary

**Signature:** /s/ Pamela Swidler  
**Date:** 2023-02-28

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**